Patient card
John Smith
Profile
January 1, 1980 (44)
JS
T2D
General Data:
Name: John Smith
Date of Birth: January 1, 1980
Gender: Male
Primary diagnosis:
Primary: Type 2 Diabetes
Anthropometric Data:
Height: 180 cm
Weight: 80 kg
Body Mass Index (BMI): 26.2
Additional diagnosis:
Additional: Hyperlipidemia
Additional 2: Please indicate diagnosis
Risk Group:
Cardiovascular Diseases: High risk (hypertension, diabetes, hyperlipidemia, family history of cardiovascular diseases).
Diabetic Complications: Moderate risk.
History of Weight and Height Changes:
  • 01/01/2024: Height 180 cm, Weight 85 kg, BMI 26.2
  • 01/01/2023: Height 180 cm, Weight 82 kg, BMI 25.3
  • 01/01/2022: Height 180 cm, Weight 80 kg, BMI 24.7
  • 01/01/2021: Height 180 cm, Weight 78 kg, BMI 24.1
Doctor's Notes:
The patient has multiple chronic conditions requiring a comprehensive treatment approach. Regular monitoring of blood pressure, blood sugar levels, and lipids is recommended. Next follow-up appointment in 3 months. Lifestyle changes to reduce cardiovascular risks should be discussed.
Medication Administration:
Medication: Losartan
Administration Time: 8:00 AM
Dosage: 50 mg
Medication: Hydrochlorothiazide
Administration Time: 8:15 AM
Dosage: 25 mg
Medication: Metformin
Administration Time: 8:30 AM and 8:30 PM
Dosage: 1000 mg
Medication: Atorvastatin
Administration Time: 9:00 PM
Dosage: 20 mg
Add medication: Please indicate medication
Last Updates:
Last Data Update: June 19, 2024, 10:00 AM
Last Physician Visit: June 18, 2024, 3:30 PM
Recent Changes in Patient Information:
Weight: Increased from 82 kg to 85 kg (change recorded on June 17, 2024).
Metformin: Administration time changed from 8:00 AM and 8:00 PM to 8:30 AM and 8:30 PM (change made on June 16, 2024).
Add changes: Please indicate last changes
Physician’s Notes:
The patient has several chronic conditions requiring a comprehensive treatment approach. Regular monitoring of blood pressure, blood sugar levels, and lipid profiles is recommended. The next follow-up examination is scheduled in 3 months. Lifestyle changes should be discussed to reduce the risk of cardiovascular complications.